注射用青蒿琥酯所致的迟发性溶血
Delayed Hemolysis With Parenteral Artesunate.
作者信息
Awuah Alfred, Shah Punit Jitendra, Tariq Farheen
机构信息
Houston Methodist Hospital, Houston, TX, USA.
Houston Methodist Sugar Land Hospital, Sugar Land, TX, USA.
出版信息
Hosp Pharm. 2023 Jun;58(3):259-262. doi: 10.1177/00185787221142471. Epub 2022 Dec 13.
Abstract
Artesunate is an effective and first-line therapy option in patients with severe malaria caused by species. Among adverse effects of the drug is a phenomenon of delayed hemolysis. This usually occurs at least 7 days after initiation of therapy, and is characterized by reductions in hemoglobin and haptoglobin and an increase in lactate dehydrogenase. Here, we report an instance of delayed hemolysis in a patient probably attributed to parenteral artesunate therapy.
摘要
青蒿琥酯是由该物种引起的严重疟疾患者的一种有效且一线的治疗选择。该药物的不良反应之一是延迟溶血现象。这通常发生在治疗开始后至少7天，其特征是血红蛋白和触珠蛋白降低以及乳酸脱氢酶升高。在此，我们报告一例可能归因于青蒿琥酯胃肠外给药治疗的延迟溶血病例。
相似文献
1
Delayed Hemolysis With Parenteral Artesunate.注射用青蒿琥酯所致的迟发性溶血
Hosp Pharm. 2023 Jun;58(3):259-262. doi: 10.1177/00185787221142471. Epub 2022 Dec 13.
2
Update on cases of delayed hemolysis after parenteral artesunate therapy for malaria - United States, 2008 and 2013.美国2008年和2013年接受青蒿琥酯注射治疗疟疾后出现迟发性溶血病例的最新情况
MMWR Morb Mortal Wkly Rep. 2014 Aug 29;63(34):753-5.
3
Anemia and transfusion requirements among Ugandan children with severe malaria treated with intravenous artesunate.接受静脉注射青蒿琥酯治疗的乌干达重症疟疾儿童的贫血情况及输血需求
Pediatr Hematol Oncol. 2020 Mar;37(2):140-152. doi: 10.1080/08880018.2019.1701161. Epub 2019 Dec 12.
4
Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study.非洲儿童重症疟疾应用注射用青蒿琥酯治疗后的迟发性溶血反应：一项双中心前瞻性研究。
J Infect Dis. 2014 Jun 15;209(12):1921-8. doi: 10.1093/infdis/jit841. Epub 2013 Dec 26.
5
Delayed haemolysis after treatment with intravenous artesunate in patients with severe malaria in India.印度重症疟疾患者静脉注射青蒿琥酯治疗后的迟发性溶血。
Malar J. 2020 Jan 22;19(1):39. doi: 10.1186/s12936-020-3120-4.
6
Delayed Hemolysis After Parenteral Artesunate Therapy for Severe Malaria in Two Returning Canadian Travelers.两名回国的加拿大旅行者接受蒿甲醚肠外治疗严重疟疾后的延迟性溶血
Am J Trop Med Hyg. 2015 Oct;93(4):819-21. doi: 10.4269/ajtmh.15-0268. Epub 2015 Aug 3.
7
Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia.静脉注射青蒿琥酯治疗重症输入性疟疾后发生的治疗后溶血：三例高疟原虫血症患者的病例报告。
Malar J. 2012 May 17;11:169. doi: 10.1186/1475-2875-11-169.
8
Intravenous Artesunate Treatment of Severe Malaria in a Patient With Systemic Lupus Erythematosus: A Case of Post-Artesunate Delayed Hemolysis.静脉注射青蒿琥酯治疗系统性红斑狼疮患者的重症疟疾：1例青蒿琥酯后延迟性溶血病例
Cureus. 2023 Aug 27;15(8):e44201. doi: 10.7759/cureus.44201. eCollection 2023 Aug.
9
Post-artesunate Delayed Hemolysis in Patients With Severe Malaria in the United States-April 2019 Through July 2021.美国严重疟疾患者青蒿琥酯治疗后延迟性溶血——2019 年 4 月至 2021 年 7 月。
Clin Infect Dis. 2023 Feb 8;76(3):e857-e863. doi: 10.1093/cid/ciac719.
10
Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as Plasmodium malariae and delayed parenteral artesunate.马来西亚沙巴因诺氏疟原虫疟疾导致的死亡：与报告为间日疟原虫和延迟使用青蒿琥酯注射剂有关。
Malar J. 2012 Aug 20;11:284. doi: 10.1186/1475-2875-11-284.
本文引用的文献
1
Delayed haemolysis after IV artesunate therapy for P. falciparum infection.静脉注射青蒿琥酯治疗恶性疟原虫感染后的迟发性溶血。
Travel Med Infect Dis. 2022 Jan-Feb;45:102230. doi: 10.1016/j.tmaid.2021.102230. Epub 2021 Dec 13.
2
Post-artemisinin delayed hemolysis after oral therapy for infection.青蒿素治疗感染后口服疗法引起的延迟性溶血。
IDCases. 2020 Mar 3;20:e00741. doi: 10.1016/j.idcr.2020.e00741. eCollection 2020.
3
Delayed haemolysis after treatment with intravenous artesunate in patients with severe malaria in India.印度重症疟疾患者静脉注射青蒿琥酯治疗后的迟发性溶血。
Malar J. 2020 Jan 22;19(1):39. doi: 10.1186/s12936-020-3120-4.
4
Artesunate-related fever and delayed hemolysis in a returning traveler.一名归国旅行者出现的青蒿琥酯相关发热及迟发性溶血
IDCases. 2015 Apr 25;2(2):63-5. doi: 10.1016/j.idcr.2015.04.002. eCollection 2015.
5
Delayed haemolysis after artesunate treatment of severe malaria - review of the literature and perspective.青蒿琥酯治疗重症疟疾后的迟发性溶血——文献复习及展望。
Travel Med Infect Dis. 2015 Mar-Apr;13(2):143-9. doi: 10.1016/j.tmaid.2015.03.003. Epub 2015 Mar 10.
6
Update on cases of delayed hemolysis after parenteral artesunate therapy for malaria - United States, 2008 and 2013.美国2008年和2013年接受青蒿琥酯注射治疗疟疾后出现迟发性溶血病例的最新情况
MMWR Morb Mortal Wkly Rep. 2014 Aug 29;63(34):753-5.
7
Case definition: postartemisinin delayed hemolysis.病例定义：青蒿素类药物治疗后迟发性溶血性贫血。
Blood. 2014 Jul 10;124(2):157-8. doi: 10.1182/blood-2014-06-578922.
8
Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.青蒿琥酯延迟性溶血是与青蒿素类药物的救生效果相关的可预测事件。
Blood. 2014 Jul 10;124(2):167-75. doi: 10.1182/blood-2014-02-555953. Epub 2014 May 23.
9
Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study.非洲儿童重症疟疾应用注射用青蒿琥酯治疗后的迟发性溶血反应：一项双中心前瞻性研究。
J Infect Dis. 2014 Jun 15;209(12):1921-8. doi: 10.1093/infdis/jit841. Epub 2013 Dec 26.
10
Malaria, erythrocytic infection, and anemia.疟疾、红细胞感染和贫血。
Hematology Am Soc Hematol Educ Program. 2009:87-93. doi: 10.1182/asheducation-2009.1.87.
Zotero 插件